Delivery Order SPE2DB20D1100-SPE2DB24FA2E0

Award Date 2/13/24
Potential Completion Date 2/14/24
Potential Value $5.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,183,147 units of Epinephrine 0.3 mg Auto-Injector (2-Packs). The award has a ceiling value of $1,150.20 and a completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA with a potential value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,261,737 units of Epinephrine 0.3 mg auto-injector two-packs. The contract has a ceiling value of $5,087.80 and a period of performance through April 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 through...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,556,651 units of 0.3 mg epinephrine auto-injectors. The $2,903.70 contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 with...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of an Epinephrine 0.15 mg auto-injector product. The award, valued at $1,794.36, has an ultimate completion date of April 4, 2024. This delivery order was issued under an existing Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,564,184,277 units of Epinephrine 0.3 mg auto-injectors. The $11,219.50 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,881,870 epinephrine 0.3 mg auto-injectors. The contract has a potential value of $1,205.64 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designations. Amerisourcebergen Drug Corp also...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,833.96 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of 4,564,097,693 units of epinephrine 0.3 mg auto-injectors. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31,...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,642,206 Epinephrine 0.15 mg auto-injectors. The contract has a potential value of $4,485.90 and a completion date of February 14, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will deliver the pharmaceutical products from its corporate office in Conshohocken,...
The Defense Logistics Agency (DLA) awarded a $3,285.82 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,773,966 units of epinephrine 0.15 mg auto-injector. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver...
The U.S. Defense Logistics Agency (DLA) awarded a $1,096.56 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,261,488 units of 0.3 mg epinephrine auto-injectors. The award is a standalone delivery order under DLA's primary contract vehicle with AmerisourceBergen, an indefinite delivery contract (IDC) with a ceiling value of $999,999,999.00 and a period of performance through December 31, 2025. This IDC enables...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA2E0
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,642,245 units of Epinephrine 0.15 mg Auto-Injectors. The contract has a potential value of $5,383.08 and a completion date of February 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.

Generated 5/14/24, 1:04 PM